Results 141 to 150 of about 24,273 (376)

Genetically Encoded Dihydroxyphenylalanine Coupled with Tyrosinase for Strain Promoted Labelling [PDF]

open access: green, 2021
Augustine George   +6 more
openalex   +1 more source

Investigating Dopamine Replacement–Associated Fluctuations in Cognition and Mood in Cognitively Unimpaired Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Non‐motor fluctuations, characterized by variability in mood and cognition, are prevalent in advanced Parkinson's disease (PD), but less is known about these fluctuations in early PD. Objective The objective was to characterize fluctuations in cognition and mood in early PD without cognitive impairment.
Abhimanyu Mahajan   +4 more
wiley   +1 more source

Effects of the Administration of 5-Hydroxydl-Tryptophan and 3,4-Dihydroxyphenylalanine on the Acquisition of a Conditioned Avoidance Response [PDF]

open access: yes, 1974
39, [3] leaves. Advisor: Kenneth LloydThe administration of 3,4-dihydroxyphenylalanine (L-Dopa) has been shown to result in the facilitation of performance while the administration of 5-hydroxytryptophan (5-HTP) results in an impairment of performance ...
Percy, Hector
core   +1 more source

Gender Is the Main Predictor of Wearing‐Off and Dyskinesia in Levodopa‐Naïve Patients with Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Evidence suggests that female gender represents a risk factor for the development of motor/nonmotor fluctuations and dyskinesia in Parkinson's disease (PD). So far, no prospective study has analyzed this aspect in relation to the introduction of levodopa treatment.
Maria Teresa Pellecchia   +41 more
wiley   +1 more source

The Impact of Deep Brain Stimulation of the Subthalamic Nucleus on Sleep–Wake Function and Circadian Rhythms in Patients with Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is a well‐established therapy in advanced Parkinson's disease (PD) improving motor and non‐motor signs including sleep. The mechanisms of sleep improvement are insufficiently understood.
Julia Steinhardt   +6 more
wiley   +1 more source

THE METABOLISM OF 3,4-DIHYDROXYPHENYLALANINE

open access: yesJournal of Biological Chemistry, 1957
Armand McMillan   +2 more
openaire   +3 more sources

Serum Protein-Bound 3,4-Dihydroxyphenylalanine and Related Products of Protein Oxidation and Chronic Hemodialysis [PDF]

open access: bronze, 2003
W. H. F. Sutherland   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy